United States Plasma Protein Therapeutics Market Report 2017

January 2017 | 115 pages | ID: UEE0E281045EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Plasma Protein Therapeutics

Revenue, means the sales value of Plasma Protein Therapeutics

This report studies sales (consumption) of Plasma Protein Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Baxter International
• Biotest
• CSL Behring
• Grifols, S.A.
• Kedrion
• Octapharma USA
• Shire Plc
• China Biologics
• Kamada

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• C1 esterase Inhibitors
• Albumins
• Immunoglobulins
• Coagulation Factors
• Others

Split by applications, this report focuses on sales, market share and growth rate of Plasma Protein Therapeutics in each application, can be divided into

• Hereditary Angioedema
• Hemophilia
• Primary Immunodeficiency Disorder
• Secondary Immunodeficiency
• Idiopathic Thrombocytopenic
• Others (Kawasaki disease, GBS, CIDP etc)

Contents

United States Plasma Protein Therapeutics Market Report 2017

1 PLASMA PROTEIN THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Classification of Plasma Protein Therapeutics
  1.2.1 C1 esterase Inhibitors
  1.2.2 Albumins
  1.2.3 Immunoglobulins
  1.2.4 Coagulation Factors
  1.2.5 Others
1.3 Application of Plasma Protein Therapeutics
  1.3.1 Hereditary Angioedema
  1.3.2 Hemophilia
  1.3.3 Primary Immunodeficiency Disorder
  1.3.4 Secondary Immunodeficiency
  1.3.5 Idiopathic Thrombocytopenic
  1.3.6 Others (Kawasaki disease, GBS, CIDP etc)
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Plasma Protein Therapeutics (2011-2021)
  1.4.1 United States Plasma Protein Therapeutics Sales and Growth Rate (2011-2021)
  1.4.2 United States Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)

2 UNITED STATES PLASMA PROTEIN THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Plasma Protein Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Plasma Protein Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Plasma Protein Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Plasma Protein Therapeutics Market Competitive Situation and Trends
  2.4.1 Plasma Protein Therapeutics Market Concentration Rate
  2.4.2 Plasma Protein Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PLASMA PROTEIN THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Plasma Protein Therapeutics Sales and Market Share by States (2011-2016)
3.2 United States Plasma Protein Therapeutics Revenue and Market Share by States (2011-2016)
3.3 United States Plasma Protein Therapeutics Price by States (2011-2016)

4 UNITED STATES PLASMA PROTEIN THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Plasma Protein Therapeutics Sales and Market Share by Type (2011-2016)
4.2 United States Plasma Protein Therapeutics Revenue and Market Share by Type (2011-2016)
4.3 United States Plasma Protein Therapeutics Price by Type (2011-2016)
4.4 United States Plasma Protein Therapeutics Sales Growth Rate by Type (2011-2016)

5 UNITED STATES PLASMA PROTEIN THERAPEUTICS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Plasma Protein Therapeutics Sales and Market Share by Application (2011-2016)
5.2 United States Plasma Protein Therapeutics Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES PLASMA PROTEIN THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

6.1 Baxter International
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.1.2.1 C1 esterase Inhibitors
    6.1.2.2 Albumins
  6.1.3 Baxter International Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Biotest
  6.2.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.2.2.1 C1 esterase Inhibitors
    6.2.2.2 Albumins
  6.2.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 CSL Behring
  6.3.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.3.2.1 C1 esterase Inhibitors
    6.3.2.2 Albumins
  6.3.3 CSL Behring Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Grifols, S.A.
  6.4.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.4.2.1 C1 esterase Inhibitors
    6.4.2.2 Albumins
  6.4.3 Grifols, S.A. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Kedrion
  6.5.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.5.2.1 C1 esterase Inhibitors
    6.5.2.2 Albumins
  6.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Octapharma USA
  6.6.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.6.2.1 C1 esterase Inhibitors
    6.6.2.2 Albumins
  6.6.3 Octapharma USA Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Shire Plc
  6.7.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.7.2.1 C1 esterase Inhibitors
    6.7.2.2 Albumins
  6.7.3 Shire Plc Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 China Biologics
  6.8.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.8.2.1 C1 esterase Inhibitors
    6.8.2.2 Albumins
  6.8.3 China Biologics Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Kamada
  6.9.2 Plasma Protein Therapeutics Product Type, Application and Specification
    6.9.2.1 C1 esterase Inhibitors
    6.9.2.2 Albumins
  6.9.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview

7 PLASMA PROTEIN THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Plasma Protein Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Plasma Protein Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET FORECAST (2016-2021)

11.1 United States Plasma Protein Therapeutics Sales, Revenue Forecast (2016-2021)
11.2 United States Plasma Protein Therapeutics Sales Forecast by Type (2016-2021)
11.3 United States Plasma Protein Therapeutics Sales Forecast by Application (2016-2021)
11.4 Plasma Protein Therapeutics Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Plasma Protein Therapeutics
Table Classification of Plasma Protein Therapeutics
Figure United States Sales Market Share of Plasma Protein Therapeutics by Type in 2015
Figure C1 esterase Inhibitors Picture
Figure Albumins Picture
Figure Immunoglobulins Picture
Figure Coagulation Factors Picture
Figure Others Picture
Table Application of Plasma Protein Therapeutics
Figure United States Sales Market Share of Plasma Protein Therapeutics by Application in 2015
Figure Hereditary Angioedema Examples
Figure Hemophilia Examples
Figure Primary Immunodeficiency Disorder Examples
Figure Secondary Immunodeficiency Examples
Figure Idiopathic Thrombocytopenic Examples
Figure Others (Kawasaki disease, GBS, CIDP etc) Examples
Figure United States Plasma Protein Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Plasma Protein Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Plasma Protein Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Plasma Protein Therapeutics Sales Share by Manufacturers
Figure 2016 Plasma Protein Therapeutics Sales Share by Manufacturers
Table United States Plasma Protein Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Plasma Protein Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Plasma Protein Therapeutics Revenue Share by Manufacturers
Table 2016 United States Plasma Protein Therapeutics Revenue Share by Manufacturers
Table United States Market Plasma Protein Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Plasma Protein Therapeutics Average Price of Key Manufacturers in 2015
Figure Plasma Protein Therapeutics Market Share of Top 3 Manufacturers
Figure Plasma Protein Therapeutics Market Share of Top 5 Manufacturers
Table United States Plasma Protein Therapeutics Sales by States (2011-2016)
Table United States Plasma Protein Therapeutics Sales Share by States (2011-2016)
Figure United States Plasma Protein Therapeutics Sales Market Share by States in 2015
Table United States Plasma Protein Therapeutics Revenue and Market Share by States (2011-2016)
Table United States Plasma Protein Therapeutics Revenue Share by States (2011-2016)
Figure Revenue Market Share of Plasma Protein Therapeutics by States (2011-2016)
Table United States Plasma Protein Therapeutics Price by States (2011-2016)
Table United States Plasma Protein Therapeutics Sales by Type (2011-2016)
Table United States Plasma Protein Therapeutics Sales Share by Type (2011-2016)
Figure United States Plasma Protein Therapeutics Sales Market Share by Type in 2015
Table United States Plasma Protein Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Plasma Protein Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Plasma Protein Therapeutics by Type (2011-2016)
Table United States Plasma Protein Therapeutics Price by Type (2011-2016)
Figure United States Plasma Protein Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Plasma Protein Therapeutics Sales by Application (2011-2016)
Table United States Plasma Protein Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Plasma Protein Therapeutics Sales Market Share by Application in 2015
Table United States Plasma Protein Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Plasma Protein Therapeutics Sales Growth Rate by Application (2011-2016)
Table Baxter International Basic Information List
Table Baxter International Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter International Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Biotest Basic Information List
Table Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotest Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Grifols, S.A. Basic Information List
Table Grifols, S.A. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols, S.A. Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Kedrion Basic Information List
Table Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Octapharma USA Basic Information List
Table Octapharma USA Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma USA Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Shire Plc Basic Information List
Table Shire Plc Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Plc Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table China Biologics Basic Information List
Table China Biologics Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologics Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Kamada Basic Information List
Table Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kamada Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protein Therapeutics
Figure Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure Plasma Protein Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2015
Table Major Buyers of Plasma Protein Therapeutics
Table Distributors/Traders List
Figure United States Plasma Protein Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Plasma Protein Therapeutics Production Forecast by Type (2016-2021)
Table United States Plasma Protein Therapeutics Consumption Forecast by Application (2016-2021)
Table United States Plasma Protein Therapeutics Sales Forecast by States (2016-2021)
Table United States Plasma Protein Therapeutics Sales Share Forecast by States (2016-2021)